Lv73
4565 积分 2021-01-24 加入
Claudin 18.2 as a novel therapeutic target
20天前
已完结
Antibody–drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry
21天前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
21天前
已完结
The present and future of bispecific antibodies for cancer therapy
21天前
已完结
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
1个月前
已完结
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
2个月前
已完结
New treatment paradigm for locally advanced cervical cancer?
2个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
2个月前
已完结
Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial
2个月前
已完结
Neoadjuvant chemotherapy followed by radical trachelectomy versus upfront abdominal radical trachelectomy for patients with FIGO 2018 stage IB2 cervical cancer
2个月前
已完结
皖公网安备34019202002308
